Risk factors for respiratory syncytial virus hospitalisation in children with heart disease

Archives of Disease in Childhood

Volumn 94, Issue 10, 2009, Pages 785-789

  Kristensen, K ^a   Stensballe, L G ^b   Bjerre, J ^c   Roth, D ^d   Fisker, N ^d   Kongstad, T ^e   Svendsen, A L ^f   Nielsen, B W ^c  

^a International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c University Hospital   (Denmark)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e HILLERØD HOSPITAL   (Denmark)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ARTICLE; ARTIFICIAL VENTILATION; CARDIOMYOPATHY; CHILD; CONTROLLED STUDY; DENMARK; DISEASE SEVERITY; DOWN SYNDROME; FEMALE; HEART DISEASE; HEART FAILURE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFANT; INFECTION RISK; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NEWBORN; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RISK ASSESSMENT; VIRUS INFECTION;

ADOLESCENT; AGE FACTORS; CARDIOMYOPATHIES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DENMARK; DOWN SYNDROME; FEMALE; HEART DISEASES; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RISK FACTORS;

EID: 70349406752     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2008.143057     Document Type: Article

References (34)

1. Simoes EA. Respiratory syncytial virus infection. Lancet 1999;354:847-852
2. Glezen WP, Taber LH, Frank AL, et al. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child 1986;140:543-546 (Pubitemid 16120909)
3. Lee MS, Walker RE, Mendelman PM. Medical burden of respiratory syncytial virus and parainfluenza virus type 3 infection among US children. Implications for design of vaccine trials. Hum Vaccin 2005;1:6-11.
4. Pedersen O, Herskind AM, Kamper J, et al. Rehospitalization for respiratory syncytial virus infection in infants with extremely low gestational age or birth weight in Denmark. Acta Paediatr 2003;92:240-242
5. Feltes TF, Cabalka AK, Meissner HC, et al. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr 2003;143:532-540
6. Fixler DE. Respiratory syncytial virus infection in children with congenital heart disease: a review. Pediatr Cardiol 1996;17:163-168 (Pubitemid 26151067)
7. Meberg A, Bruu AL. Respiratory syncytial virus infections in congenital heart defects - hospitalizations and costs. Acta Paediatr 2006;95:404-406
8. Rackham OJ, Thorburn K, Kerr SJ. The potential impact of prophylaxis against bronchiolitis due to the respiratory syncytial virus in children with congenital cardiac malformations. Cardiol Young 2005;15:251-255 (Pubitemid 41388051)
9. The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics 1998;102:531-537
10. Stensballe LG, Kristensen K, Nielsen J, et al. Diagnosis coding in The Danish National Patient Registry for respiratory syncytial virus infections. Scand J Infect Dis 2005;37:747-752 (Pubitemid 41600948)
11. Kapikian AZ, Bell JA, Mastrota FM, et al. An outbreak of febrile illness and pneumonia associated with respiratory syncytial virus infection. Am J Hyg 1961;74:234-248
12. Bloemers BL, van Furth AM, Weijerman ME, et al. Down syndrome: a novel risk factor for respiratory syncytial virus bronchiolitis - a prospective birth-cohort study. Pediatrics 2007;120:e1076-81.
13. Fjaerli HO, Farstad T, Bratlid D. Hospitalisations for respiratory syncytial virus bronchiolitis in Akershus, Norway, 1993-2000: a population-based retrospective study. BMC Pediatr 2004;4:25.
14. Hilton JM, Fitzgerald DA, Cooper DM. Respiratory morbidity of hospitalized children with Trisomy 21. J Paediatr Child Health 1999;35:383-386
15. Yang Q, Rasmussen SA, Friedman JM. Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet 2002;359:1019-1025
16. Schloo BL, Vawter GF, Reid LM. Down syndrome: patterns of disturbed lung growth. Hum Pathol 1991;22:919-923
17. Bertrand P, Navarro H, Caussade S, et al. Airway anomalies in children with Down syndrome: endoscopic findings. Pediatr Pulmonol 2003;36:137-141 (Pubitemid 36959553)
18. de Hingh YC, van der Vossen PW, Gemen EF, et al. Intrinsic abnormalities of lymphocyte counts in children with Down syndrome. J Pediatr 2005;147:744-747
19. Scotese I, Gaetaniello L, Matarese G, et al. T cell activation deficiency associated with an aberrant pattern of protein tyrosine phosphorylation after CD3 perturbation in Down's syndrome. Pediatr Res 1998;44:252-258 (Pubitemid 28347905)
20. Chaney RH, Eyman RK, Miller CR. The relationship of congenital heart disease and respiratory infection mortality in patients with Down's syndrome. J Ment Defic Res 1985;29:23-27 (Pubitemid 15051976)
21. Altman CA, Englund JA, Demmler G, et al. Respiratory syncytial virus in patients with congenital heart disease: a contemporary look at epidemiology and success of preoperative screening. Pediatr Cardiol 2000;21:433-438 (Pubitemid 30676877)
22. Habre W, Schutz N, Pellegrini M, et al. Preoperative pulmonary hemodynamics determines changes in airway and tissue mechanics following surgical repair of congenital heart diseases. Pediatr Pulmonol 2004;38:470-476 (Pubitemid 39565219)
23. Polese G, Lubli P, Mazzucco A, et al. Effects of open heart surgery on respiratory mechanics. Intensive Care Med 1999;25:1092-1099 (Pubitemid 29525064)
24. Hamano K, Gohra H, Katoh T, et al. Late postoperative respiratory function in adults after surgical correction of atrial septal defects. Analysis of respiratory dysfunction patterns. Scand Cardiovasc J 1998;32:135-136 (Pubitemid 28418228)
25. Schofield PM, Barber PV, Kingston T. Preoperative and postoperative pulmonary function tests in patients with atrial septal defect and their relation to pulmonary artery pressure and pulmonary: systemic flow ratio. Br Heart J 1985;54:577-582 (Pubitemid 16126823)
26. Sulc J, Samanek M, Zapletal A. Lung function in atrial septal defect after heart surgery. Int J Cardiol 1992;37:15-21.
27. Sulc J, Andrle V, Hruda J, et al. Pulmonary function in children with atrial septal defect before and after heart surgery. Heart 1998;80:484-488 (Pubitemid 28535537)
28. Carpenter TC, Stenmark KR. Predisposition of infants with chronic lung disease to respiratory syncytial virus-induced respiratory failure: a vascular hypothesis. Pediatr Infect Dis J 2004;23(1 Suppl):S33-40.
29. Duppenthaler A, Ammann RA, Gorgievski-Hrisoho M, et al. Low incidence of respiratory syncytial virus hospitalisations in haemodynamically significant congenital heart disease. Arch Dis Child 2004;89:961-965 (Pubitemid 39331390)
30. Medrano C, Garcia-Guereta L, Grueso J, et al. Respiratory infection in congenital cardiac disease. Hospitalizations in young children in Spain during 2004 and 2005: the CIVIC Epidemiologic Study. Cardiol Young 2007;17:360-371
31. Henrickson KJ, Hall CB. Diagnostic assays for respiratory syncytial virus disease. Pediatr Infect Dis J 2007;26(11 Suppl):S36-40.
32. Nielsen HE, Siersma V, Andersen S, et al. Respiratory syncytial virus infection - risk factors for hospital admission: a case-control study. Acta Paediatr 2003;92:1314-1321
33. Stensballe LG, Kristensen K, Simoes EAF, et al. Atopic disposition, wheezing, and subsequent respiratory syncytial virus hospitalization in Danish children younger than 18 months: a nested case-control study. Pediatrics 2006;118:e1360-8. (Pubitemid 46393640)
34. Kallen K. Maternal smoking and congenital heart defects. Eur J Epidemiol 1999;15:731-737 (Pubitemid 29493113)